These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

232 related items for PubMed ID: 34537845

  • 1. The Relationship Between Continuous Glucose Monitoring and OGTT in Youth and Young Adults With Cystic Fibrosis.
    Chan CL, Pyle L, Vigers T, Zeitler PS, Nadeau KJ.
    J Clin Endocrinol Metab; 2022 Jan 18; 107(2):e548-e560. PubMed ID: 34537845
    [Abstract] [Full Text] [Related]

  • 2. Oral glucose tolerance test and continuous glucose monitoring to assess diabetes development in cystic fibrosis patients.
    Clemente León M, Bilbao Gassó L, Moreno-Galdó A, Campos Martorrell A, Gartner Tizzano S, Yeste Fernández D, Carrascosa Lezcano A.
    Endocrinol Diabetes Nutr (Engl Ed); 2018 Jan 18; 65(1):45-51. PubMed ID: 29137964
    [Abstract] [Full Text] [Related]

  • 3. Continuous glucose monitoring and advanced glycation endproducts for prediction of clinical outcomes and development of cystic fibrosis-related diabetes in adults with CF.
    Scully KJ, Brenner L, Martin K, Ruazol M, Sawicki GS, Uluer A, Neuringer I, Yonker LM, Sicilian L, Putman MS.
    Front Endocrinol (Lausanne); 2024 Jan 18; 15():1293709. PubMed ID: 38379863
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Hypoglycemia in children and young adults with cystic fibrosis during oral glucose tolerance testing vs. continuous glucose monitoring.
    Finn E, Severn C, Pyle L, Garrish J, Vigers T, Behn CGD, Zeitler PS, Sagel SD, Nadeau KJ, Chan CL.
    Pediatr Pulmonol; 2023 Sep 18; 58(9):2495-2504. PubMed ID: 37350354
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Early assessment of glucose abnormalities during continuous glucose monitoring associated with lung function impairment in cystic fibrosis patients.
    Leclercq A, Gauthier B, Rosner V, Weiss L, Moreau F, Constantinescu AA, Kessler R, Kessler L.
    J Cyst Fibros; 2014 Jul 18; 13(4):478-84. PubMed ID: 24359972
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Predictors for future cystic fibrosis-related diabetes by oral glucose tolerance test.
    Schmid K, Fink K, Holl RW, Hebestreit H, Ballmann M.
    J Cyst Fibros; 2014 Jan 18; 13(1):80-5. PubMed ID: 23809507
    [Abstract] [Full Text] [Related]

  • 12. Glycemia and β-cell function before and after elexacaftor/tezacaftor/ivacaftor in youth and adults with cystic fibrosis.
    Chan CL, Granados A, Moheet A, Singh S, Vigers T, Arbeláez AM, Yi Y, Hu S, Norris AW, Ode KL.
    J Clin Transl Endocrinol; 2022 Dec 18; 30():100311. PubMed ID: 36620757
    [Abstract] [Full Text] [Related]

  • 13. Disposition index identifies defective beta-cell function in cystic fibrosis subjects with normal glucose tolerance.
    Merjaneh L, He Q, Long Q, Phillips LS, Stecenko AA.
    J Cyst Fibros; 2015 Jan 18; 14(1):135-41. PubMed ID: 24998161
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Value of continuous glucose monitoring in screening for diabetes in cystic fibrosis].
    Khammar A, Stremler N, Dubus JC, Gross G, Sarles J, Reynaud R.
    Arch Pediatr; 2009 Dec 18; 16(12):1540-6. PubMed ID: 19854630
    [Abstract] [Full Text] [Related]

  • 16. Can continuous glucose monitoring predict cystic fibrosis-related diabetes and worse clinical outcome?
    Zorron M, Marson FAL, Morcillo AM, Gonçalves AC, El Beck MS, Ribeiro JD, Ribeiro AF.
    J Bras Pneumol; 2022 Dec 18; 48(2):e20210307. PubMed ID: 35475864
    [Abstract] [Full Text] [Related]

  • 17. HbA1c as a screening tool for cystic fibrosis related diabetes.
    Burgess JC, Bridges N, Banya W, Gyi KM, Hodson ME, Bilton D, Simmonds NJ.
    J Cyst Fibros; 2016 Mar 18; 15(2):251-7. PubMed ID: 25869326
    [Abstract] [Full Text] [Related]

  • 18. Peak glucose during an oral glucose tolerance test is associated with future diabetes risk in adults with cystic fibrosis.
    Bonhoure A, Potter KJ, Colomba J, Boudreau V, Bergeron C, Desjardins K, Carricart M, Tremblay F, Lavoie A, Rabasa-Lhoret R.
    Diabetologia; 2021 Jun 18; 64(6):1332-1341. PubMed ID: 33693987
    [Abstract] [Full Text] [Related]

  • 19. Continuous Glucose Monitoring and HbA1c in Cystic Fibrosis: Clinical Correlations and Implications for CFRD Diagnosis.
    Scully KJ, Sherwood JS, Martin K, Ruazol M, Marchetti P, Larkin M, Zheng H, Sawicki GS, Uluer A, Neuringer I, Yonker LM, Sicilian L, Wexler DJ, Putman MS.
    J Clin Endocrinol Metab; 2022 Mar 24; 107(4):e1444-e1454. PubMed ID: 34850006
    [Abstract] [Full Text] [Related]

  • 20. MARKEDLY DELAYED INSULIN SECRETION AND A HIGH RATE OF UNDETECTED OVERT DIABETES CHARACTERIZE GLUCOSE METABOLISM IN ADULT PATIENTS WITH CYSTIC FIBROSIS AFTER LUNG TRANSPLANTATION.
    Winhofer Y, Wolf P, Fellinger P, Tura A, Hillebrand P, Staufer K, Trauner M, Jaksch P, Muraközy G, Kautzky-Willer A, Pacini G, Krebs M, Luger A, Kazemi-Shirazi L.
    Endocr Pract; 2019 Mar 24; 25(3):254-262. PubMed ID: 30913015
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.